Jonathan A Javitch MD
Lieber Professor of Experimental Therapeutics (in Psychiatry) Professor of Pharmacology (in the Center for Molecular Recognition and in Physiology and Cellular Biophysics) Chief, Division of Molecular Therapeutics Director, Lieber Center for Schizophrenia Research and Treatment
Join to View Full Profile
630 W 168th St# CenterNew York, NY 10032
Phone+1 212-305-7308
Fax+1 775-898-5133
Dr. Javitch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1986 - 1990
- Johns Hopkins University School of MedicineClass of 1986
Certifications & Licensure
- NY State Medical License 1987 - 2027
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- Complex G-protein signaling of the adhesion GPCR, ADGRA3.Sofie M Bagger, Hannes Schihada, Anna L S Walser, Anna Katarzyna Drzazga, Lukas Grätz
The Journal of Biological Chemistry. 2025-03-22 - N-terminal fragment shedding contributes to signaling of the full-length adhesion receptor ADGRL3.Nicole A Perry-Hauser, Jonathan R Du Rand, Kuo Hao Lee, Lei Shi, Jonathan A Javitch
The Journal of Biological Chemistry. 2025-02-01 - Elucidating the molecular logic of a metabotropic glutamate receptor heterodimer.Xin Lin, Davide Provasi, Colleen M Niswender, Wesley B Asher, Jonathan A Javitch
Nature Communications. 2024-10-03
Journal Articles
- Arrestin Recruitment to Dopamine D2 Receptor Mediates Locomotion but Not Incentive MotivationJonathan Javitch, MD, Nature
Press Mentions
- 2022 Leading Research AchievementsJanuary 5th, 2023
- CUIMC Update - April 12, 2021April 12th, 2021
- HDRF Honors Taraji P. Henson and Jane Pauley at 14th Virtual Annual HOPE LuncheonNovember 20th, 2020
- Join now to see all
Grant Support
- Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacologyNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2023–2028
- Pleiotropic pathways of extracellular calcium sensingCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2026
- Pleiotropic pathways of extracellular calcium sensingCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2026
- Pleiotropic pathways of extracellular calcium sensingCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2026
- Pleiotropic pathways of extracellular calcium sensingCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2026
- Pleiotropic pathways of extracellular calcium sensingCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2026
- Structure and Function of Dopamine ReceptorsNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1995–2026
- Structure and Function of Dopamine ReceptorsNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1995–2026
- Structure and Function of Dopamine ReceptorsNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1995–2026
- Structure and Function of Dopamine ReceptorsNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1995–2026
- Functional validation of a role for the candidate gene Ctr9 in psychostimulant actionNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2022–2025
- P3 - Regulation Of Dopamine Transporter FunctionNational Institute On Drug Abuse2011–2012
- Functional Properties Of Protein Segments In Receptors And TransportersNational Institute On Drug Abuse2009–2012
- Training In Schizophrenia And Psychotic Disorders: From Animal Models To PatientsNational Institute Of Mental Health2010–2011
- Molecular Mechanisms Of Bacterial Homologs Of Neurotransmitter:Sodium SymportersNational Institute On Drug Abuse2009–2011
- Molecular Determinants For The Action Of PsychostimulantsNational Institute On Drug Abuse2007–2011
- Schizophrenia Research FellowshipNational Institute Of Mental Health2007–2009
- Structure And Function Of The Dopamine TransporterNational Institute On Drug Abuse2005–2009
- Dopamine Transporter: Substrate &Cocaine Binding SitesNational Institute On Drug Abuse2006–2007
- Archaeal &Bacterial Homologs Of Dopamine TransporterNational Institute On Drug Abuse2003–2007
- Molecular Recognition Of Antipsychotic Drugs And CocaineNational Institute Of Mental Health1997–2006
- 2004 &2006 Membrane Transport Proteins Gordon ConferenceNational Institute Of Mental Health2004–2005
- Dopamine Transporter: Substrate &Cocaine Binding SitesNational Institute On Drug Abuse2003–2005
- Archaeal &Bacterial Homologs Of Dopamine TransporterNational Institute On Drug Abuse2001–2002
- Structure/Function Of The Human Dopamine TransporterNational Institute On Drug Abuse1999–2002
- Dopamine Transporter--Substrate &Cocaine Binding SitesNational Institute On Drug Abuse1998–2002
- Molecular Recognition Of Antipsychotic DrugsNational Institute Of Mental Health1995–1996
- Molecular Recognition Of Antipsychotic DrugsNational Institute Of Mental Health1992–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
